查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
合約研發組織服務市場（按類型、治療領域、模式、最終用戶和地區分類）—預測至 2030 年
市場調查報告書
商品編碼
1816001

合約研發組織服務市場（按類型、治療領域、模式、最終用戶和地區分類）—預測至 2030 年

Contract Research Organization Services Market by Type, Therapeutic Area (Cancer, Infectious, Neurology, Vaccines), Modality - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 634 Pages | 訂單完成後即時交付

價格

合約研究組織 (CRO) 服務市場預計將從 2025 年的 846.1 億美元成長到 2030 年的 1,259.5 億美元，預測期內的複合年成長率為 8.3%。

市場成長的主要驅動力包括不斷擴大的細胞和基因療法管道以及對精準醫療的日益關注，預計這些將推動贊助商對能夠處理複雜設計、基因組篩檢、可客製化物流和內部難以獲得的必要長期追蹤能力的 CRO 合作夥伴的興趣。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
對價單位 金額（十億美元）
部分 按類型、治療領域、治療方式、最終使用者、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

隨著精準計畫細分患者群體並縮短入組週期，整合的CRO實驗室網路和全球站點覆蓋對於時間表和數據品質至關重要。由於監管機構和付款方要求提供可靠的即時證據，申辦方越來越依賴能夠提供臨床營運、擁有先進實驗室、資料科學和RWE能力的CRO來降低開發風險。

合約研究組織服務市場-IMG1

根據服務類型，早期開發服務部分將在 2024 年佔據 CRO 服務市場的最大佔有率。

依服務類型分類，CRO服務市場分為臨床研究服務、早期開發服務、化驗服務、諮詢服務和資料管理服務。預計到2024年，早期開發服務將佔據最大的市場佔有率。目前的研發管線專注於新型生技藥品、CGT和標靶治療的開發，這些領域需要專業的毒理學、DMPK、生物分析和安全藥理學。

根據最終用戶，製藥和生物製藥公司在 2024 年佔據 CRO 服務市場的最大佔有率。

根據最終用戶，CRO服務市場細分為製藥和生物製藥公司、醫療設備公司和學術機構。到2024年，製藥和生物製藥公司將佔據CRO服務市場的最大佔有率。該最終用戶細分市場的巨大佔有率可歸因於製藥和生物技術公司擁有大量的藥物研發線產品。此外，CRO提供快速、規模化和靈活的成本基礎，從而吸引最終用戶。

按地區分類，北美將在 2024 年佔據最大的市場佔有率。

預計到2024年，北美將佔據全球CRO服務市場的最大佔有率。這得歸功於其成熟的製藥和生物技術產業，這推動了對外包研發服務的巨大需求。此外，該地區擁有龐大的臨床站點、醫院和專業設施網路，為大規模臨床試驗提供了理想的基礎設施。此外，美國數位醫療解決方案和分散式臨床試驗模式的快速普及，也顯著提升了該地區的市場佔有率，隨著申辦方尋求創新方法來改善患者招募和保留，進一步推動了對CRO的需求。

本報告研究了全球合約研究與開發組織服務市場，按類型、治療領域、方式、最終用戶和地區對其進行細分，並提供了參與市場的公司概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章 市場概況

  • 介紹
  • 市場動態

第6章 產業趨勢

  • 市場趨勢
  • 影響客戶業務的趨勢/中斷
  • 定價分析
  • 價值鏈分析
  • 生態系分析
  • 投資/資金籌措活動
  • 技術分析
  • 大型會議及活動
  • 監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準
  • 客戶狀況
  • 人工智慧/產生人工智慧對CRO服務市場的影響
  • 2025年川普關稅對CRO服務市場的影響

第7章 CRO 服務市場（按類型）

  • 介紹
  • 臨床研究服務
  • 早期開發服務
  • 化驗服務
  • 諮詢服務
  • 資料管理服務

8. CRO服務市場（按治療領域）

  • 介紹
  • 瘤
  • 感染疾病
  • 心血管疾病
  • 神經系統疾病
  • 疫苗
  • 代謝/內分泌失調
  • 免疫疾病
  • 精神病學
  • 呼吸系統疾病
  • 皮膚科
  • 眼科
  • 消化系統疾病
  • 泌尿生殖系統與婦女健康
  • 血液學
  • 其他

9. CRO 服務市場（按模式）

  • 介紹
  • 小分子
  • 生物學
  • 醫療設備
  • 生物相似藥

第 10 章 CRO 服務市場（按最終用戶）

  • 介紹
  • 製藥和生物製藥公司
  • 醫療設備公司
  • 學術機構

第 11 章 CRO 服務市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東
    • 中東宏觀經濟展望
    • 海灣合作理事會國家
  • 非洲
    • 蓬勃發展的製藥業推動成長
    • 非洲宏觀經濟展望

第12章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2020-2024年收益分析
  • 2024年市佔率分析
  • 估值和財務指標
  • 品牌/服務比較
  • 公司估值矩陣：2024 年關鍵參與企業
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 競爭場景

第13章：公司簡介

  • 主要參與企業
    • IQVIA INC.
    • ICON PLC
    • THERMO FISHER SCIENTIFIC INC.
    • LABCORP
    • FORTREA, INC.
    • SYNEOS HEALTH
    • WUXI APPTEC
    • CHARLES RIVER LABORATORIES
    • PAREXEL INTERNATIONAL CORPORATION
    • PHARMARON
    • MEDPACE
    • SGS SOCIETE GENERALE DE SURVEILLANCE SA
    • FRONTAGE LABS
    • EUROFINS SCIENTIFIC
    • TIGERMED
    • PSI
    • BIOAGILE THERAPEUTICS PRIVATE LIMITED
    • FIRMA CLINICAL RESEARCH
    • ACCULAB LIFE SCIENCES
    • NOVOTECH
    • LINICAL
    • ADVANCED CLINICAL
  • 其他公司
    • ALLUCENT
    • EMVENIO
    • GUIRES INC.
    • WORLDWIDE CLINICAL TRIALS
    • CTI CLINICAL TRIAL & CONSULTING

第14章 附錄

Product Code: PH 4672

The Contract Research Organization (CRO) services market is expected to reach USD 125.95 billion in 2030 from USD 84.61 billion in 2025, at a CAGR of 8.3% during the forecast period. The key factors contributing to market growth include the expanding pipeline of cell & gene therapies and the growing focus on precision medicine. These factors are expected to fuel sponsors towards CRO partners that can handle complex designs, genomic screening, customizable logistics, and mandatory long-term follow-up capabilities that are challenging to utilize in-house.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsService Type, Modality, and End User
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

Precision programs fragment patient cohorts and shorten enrollment windows, making integrated CRO-lab networks and global site coverage decisive for timelines and data quality. As regulators and payers demand robust, real-time evidence, sponsors increasingly depend on CROs that offer clinical operations with advanced lab, data science, and RWE capabilities to de-risk development.

Contract Research Organization Services Market - IMG1

By service type, the early phase development services segment accounted for the largest share of the CRO services market in 2024.

Based on service type, the CRO services market is segmented into clinical research services, early phase development services, laboratory services, consulting services, and data management services. In 2024, the early phase development services segment accounted for the largest share of the market. The current pipeline is focused on developing novel biologics, CGT, and targeted modalities that require specialized toxicology, DMPK, bioanalysis, and safety pharmacology, which several sponsors prefer to outsource to reach the IND (investigational new drug) stage faster.

By end user, the pharmaceutical & biopharmaceutical companies accounted for the largest share in the CRO services market in 2024.

Based on end user, the CRO services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. In 2024, the pharmaceutical & biopharmaceutical companies segment accounted for the largest share of the CRO services market. The large share of this end-user segment can be attributed to the large number of drug pipeline products of pharma and biotech companies. Moreover, CROs deliver speed, scale, and flexible cost bases, attracting end users.

By region, North America accounted for the largest share of the market in 2024.

In 2024, North America held the largest share of the global CRO services market, driven by the presence of well-established pharmaceutical and biotechnology industries, which drive significant demand for outsourced research and development services. Additionally, a vast network of clinical sites, hospitals, and specialized facilities, providing an ideal infrastructure for conducting large-scale clinical trials, is present in the region. Additionally, the rapid adoption of digital health solutions and decentralized trial models in the US, a significant contributor to the substantial share of the region, is further boosting CRO demand, as sponsors seek innovative ways to improve patient recruitment and retention.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply-side- 70% and Demand-side 30%
  • By Designation: Managers - 45%, CXOs & Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe -25%, Asia Pacific -25%, Latin America -5%, and the Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • IQVIA Inc. (US)
  • ICON plc (Ireland)
  • Thermo Fisher Scientific Inc. (US)
  • Laboratory Corporation of America Holdings (LabCorp) (US)
  • Fortrea, Inc. (US)
  • Syneos Health (US)
  • WuXi AppTec (China)
  • Charles River Laboratories (US)
  • Parexel International Corporation (US)
  • Pharmaron (China)
  • Medpace (US)
  • SGS SA (Switzerland), Frontage Labs (US)
  • Eurofins Scientific (Luxembourg)
  • BioAgile (India)
  • Firma Clinical Research (US)
  • Acculab Life Sciences (US)
  • Novotech (Australia)
  • KCR S.A. (US)
  • Linical (Japan)
  • Advanced Clinical (US)
  • Allucent (US)
  • Clinical Trial Service (Netherlands)
  • Guires Inc. (Pepgra Healthcare Pvt. Ltd.) (UK)
  • Worldwide Clinical Trials (US)
  • CTI Clinical Trial And Consulting (US)

Research Coverage

This research report categorizes the CRO services market by service type (clinical research services, early phase development services, laboratory services, consulting services, and data management services), modality (small molecules, biologics, biosimilars, medical devices), end user (pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes), and regional scope (North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa). The report covers detailed information regarding the leading factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the CRO services market. A thorough analysis of the key industry players has provided insights into their business overview, services, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, partnerships, and acquisitions are the recent developments associated with the CRO services market.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall CRO services market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (Increasing focus on decentralized trials, rising complexity and volume of trials, service flexibility offered by CROs), opportunities (regulatory focus on patient pool diversity), and challenges (challenges of patient retention and cybersecurity/intellectual property concerns) influencing the growth of the market.
  • Service Development/Innovation: Detailed insights on newly launched services of the CRO services market
  • Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the CRO services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of key players, including IQVIA Inc. (US), ICON Plc (Ireland), Medpace (US), Laboratory Corporation of America Holdings (LabCorp) (US), Thermo Fisher Scientific Inc. (US), and Fortrea, Inc. (US). A detailed analysis of the key industry players has been conducted to provide insights into their key strategies, service launches, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/service comparative analysis, and vendor valuation and financial metrics of the CRO services market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key objectives of primary research
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
    • 2.2.2 MNM REPOSITORY ANALYSIS AND PRIMARY RESEARCH
    • 2.2.3 DEMAND AND SUPPLY-SIDE ANALYSIS
    • 2.2.4 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
  • 2.3 GROWTH RATE PROJECTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

  • 3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN CRO SERVICES MARKET
  • 3.3 DISRUPTIVE TRENDS SHAPING CRO SERVICES MARKET
  • 3.4 HIGH GROWTH SEGMENTS AND EMERGING FRONTIERS

4 PREMIUM INSIGHTS

  • 4.1 GLOBAL CRO SERVICES MARKET SNAPSHOT
  • 4.2 NORTH AMERICA: CRO SERVICES MARKET, BY MODALITY AND COUNTRY, 2024
  • 4.3 CRO SERVICES MARKET, BY TYPE, 2024
  • 4.4 CRO SERVICES MARKET, BY END USER, 2024
  • 4.5 CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.6 UNMET NEEDS AND WHITE SPACES
  • 4.7 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
  • 4.8 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT
  • 4.9 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.10 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising clinical trial volume and escalating protocol complexity
      • 5.2.1.2 Growing focus on decentralized/patient-centric trials
      • 5.2.1.3 Increasing preference for service flexibility
      • 5.2.1.4 Technological integration
      • 5.2.1.5 Growing R&D budgets and expanding late-stage pipelines
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Shift toward regulatory compliance
      • 5.2.2.2 Growing adoption of risk-based monitoring
      • 5.2.2.3 Favorable reimbursement scenario
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Patient retention
      • 5.2.3.2 Cybersecurity and intellectual property challenges

6 INDUSTRY TRENDS

  • 6.1 MARKET TRENDS
    • 6.1.1 HEALTH ECONOMICS & OUTCOMES RESEARCH AND REAL-WORLD EVIDENCE
    • 6.1.2 IN-SILICO TRIALS
    • 6.1.3 SPECIALIZED ANALYTICS FOR EMERGING MODALITIES
  • 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.3 PRICING ANALYSIS
    • 6.3.1 INDICATIVE PRICING ANALYSIS, BY SERVICE TYPE
    • 6.3.2 INDICATIVE PRICING ANALYSIS, BY PHASE
    • 6.3.3 INDICATIVE PRICING ANALYSIS, BY REGION
  • 6.4 VALUE CHAIN ANALYSIS
  • 6.5 ECOSYSTEM ANALYSIS
  • 6.6 INVESTMENT/FUNDING ACTIVITY
  • 6.7 TECHNOLOGY ANALYSIS
    • 6.7.1 KEY TECHNOLOGIES
      • 6.7.1.1 Clinical trial management system
      • 6.7.1.2 Randomization and trial supply management
      • 6.7.1.3 Electronic Data Capture (EDC) system
    • 6.7.2 COMPLEMENTARY TECHNOLOGIES
      • 6.7.2.1 Model-informed drug development
      • 6.7.2.2 Data management and informatics technologies
    • 6.7.3 ADJACENT TECHNOLOGIES
      • 6.7.3.1 Clinical trial simulation tools
  • 6.8 KEY CONFERENCES AND EVENTS
  • 6.9 REGULATORY LANDSCAPE
    • 6.9.1 REGULATORY FRAMEWORK
      • 6.9.1.1 North America
      • 6.9.1.2 Europe
      • 6.9.1.3 Asia Pacific
      • 6.9.1.4 Rest of the World
    • 6.9.2 REGULATORY ANALYSIS
    • 6.9.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.9.4 REGULATORY SCENARIO FOR DRUG APPROVALS AND CGMP PROCEDURES
  • 6.10 PORTER'S FIVE FORCES ANALYSIS
    • 6.10.1 BARGAINING POWER OF SUPPLIERS
    • 6.10.2 BARGAINING POWER OF BUYERS
    • 6.10.3 THREAT OF NEW ENTRANTS
    • 6.10.4 THREAT OF SUBSTITUTES
    • 6.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.11.2 BUYING CRITERIA
  • 6.12 CUSTOMER LANDSCAPE
    • 6.12.1 BUDGET ALLOCATION TREND
    • 6.12.2 ADOPTION BARRIER AND INTERNAL FRICTION
  • 6.13 IMPACT OF AI/GEN AI ON CRO SERVICES MARKET
    • 6.13.1 INTRODUCTION
    • 6.13.2 MARKET POTENTIAL ACROSS DRUG DEVELOPMENT STAGES
    • 6.13.3 AI USE CASES
    • 6.13.4 KEY COMPANIES IMPLEMENTING AI
    • 6.13.5 FUTURE OF GENERATIVE AI IN DRUG DEVELOPMENT ECOSYSTEM
  • 6.14 IMPACT OF 2025 TRUMP TARIFF ON CRO SERVICES MARKET
    • 6.14.1 INTRODUCTION
    • 6.14.2 KEY TARIFF RATES
    • 6.14.3 PRICE IMPACT ANALYSIS
    • 6.14.4 IMPACT ON COUNTRY/REGION
      • 6.14.4.1 North America (US)
      • 6.14.4.2 Europe
      • 6.14.4.3 Asia Pacific
    • 6.14.5 IMPACT ON END-USE INDUSTRIES
      • 6.14.5.1 Pharmaceutical & biotech companies
      • 6.14.5.2 Medical device companies
      • 6.14.5.3 Academic institutes

7 CRO SERVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL RESEARCH SERVICES
    • 7.2.1 PHASE III
      • 7.2.1.1 Large-scale testing ability to assess efficacy and safety of drugs to aid growth
    • 7.2.2 PHASE II
      • 7.2.2.1 Growing number of pipeline products in Phase II studies to drive market
    • 7.2.3 PHASE I
      • 7.2.3.1 Robust pipeline of pharmaceutical and biopharmaceutical products to support growth
    • 7.2.4 PHASE IV
      • 7.2.4.1 Stringent global regulations for drug safety monitoring to spur growth
  • 7.3 EARLY PHASE DEVELOPMENT SERVICES
    • 7.3.1 CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES
      • 7.3.1.1 Growing need to meet regulatory norms for drugs to fuel market
    • 7.3.2 PRECLINICAL SERVICES
      • 7.3.2.1 Pharmacokinetics/Pharmacodynamics
        • 7.3.2.1.1 Rise in outsourcing services by pharmaceutical and biopharmaceutical companies to promote growth
      • 7.3.2.2 Toxicology testing
        • 7.3.2.2.1 Need to prevent late-stage failures to contribute to growth
      • 7.3.2.3 Other preclinical services
    • 7.3.3 DISCOVERY STUDIES
      • 7.3.3.1 Increasing reliance on CRO services for target identification and validation to expedite growth
  • 7.4 LABORATORY SERVICES
    • 7.4.1 ANALYTICAL TESTING
      • 7.4.1.1 Physical characterization
        • 7.4.1.1.1 Ability to minimize product failure in late-phase development to favor growth
      • 7.4.1.2 Raw material testing
        • 7.4.1.2.1 Need to maintain quality of finished product to facilitate growth
      • 7.4.1.3 Batch-release testing
        • 7.4.1.3.1 Need to maintain batch-to-batch consistency of pharmaceutical dosage forms to advance growth
      • 7.4.1.4 Stability testing
        • 7.4.1.4.1 Ability to establish drug compatibility and formulation development to aid growth
      • 7.4.1.5 Other analytical testing services
    • 7.4.2 BIOANALYTICAL TESTING
      • 7.4.2.1 Increasing outsourcing of R&D activities to accelerate growth
  • 7.5 CONSULTING SERVICES
    • 7.5.1 GROWING ADOPTION OF CONSULTING SERVICES FOR FASTER REGULATORY APPROVALS TO BOOST MARKET
  • 7.6 DATA MANAGEMENT SERVICES
    • 7.6.1 NEED TO TRACK PROGRESS OF EARLY DRUG DEVELOPMENT TO AUGMENT GROWTH

8 CRO SERVICES MARKET, BY THERAPEUTIC AREA

  • 8.1 INTRODUCTION
  • 8.2 ONCOLOGY
    • 8.2.1 BREAST CANCER
      • 8.2.1.1 Increasing cases and high spending on treating breast cancer to support growth
    • 8.2.2 LUNG CANCER
      • 8.2.2.1 Increasing focus on developing drugs against lung cancer to foster growth
    • 8.2.3 COLORECTAL CANCER
      • 8.2.3.1 Increasing drug discovery and development efforts against colorectal cancer to aid growth
    • 8.2.4 PROSTATE CANCER
      • 8.2.4.1 Growing clinical pipeline to propel market
    • 8.2.5 OTHER CANCERS
  • 8.3 INFECTIOUS DISEASES
    • 8.3.1 INCREASING INCIDENCE OF CHRONIC INFECTIONS TO SUPPORT GROWTH
  • 8.4 CARDIOVASCULAR SYSTEM DISORDERS
    • 8.4.1 HIGH MORTALITY RATES DUE TO CARDIOVASCULAR DISEASES TO FUEL MARKET
  • 8.5 NEUROLOGY
    • 8.5.1 GROWING INVESTMENTS IN NEUROLOGICAL DISORDER RESEARCH TO DRIVE MARKET
  • 8.6 VACCINES
    • 8.6.1 INCREASING FOCUS ON VACCINE DEVELOPMENT TO SPUR GROWTH
  • 8.7 METABOLIC DISORDERS/ENDOCRINOLOGY
    • 8.7.1 INCREASING GLOBAL DIABETES AND OBESITY POPULATION TO PROMOTE GROWTH
  • 8.8 IMMUNOLOGICAL DISORDERS
    • 8.8.1 GROWING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO BOOST MARKET
  • 8.9 PSYCHIATRY
    • 8.9.1 RISING CASES OF PSYCHIATRIC DISORDERS AND DEPRESSION TO SUSTAIN GROWTH
  • 8.10 RESPIRATORY DISORDERS
    • 8.10.1 RISING INCIDENCE OF CHRONIC RESPIRATORY DISEASE TO FOSTER GROWTH
  • 8.11 DERMATOLOGY
    • 8.11.1 GROWING FOCUS ON DRUG DEVELOPMENT AGAINST VARIOUS SKIN CONDITIONS TO DRIVE MARKET
  • 8.12 OPHTHALMOLOGY
    • 8.12.1 GROWTH IN OPHTHALMOLOGY PIPELINE DRUGS TO SUPPORT MARKET
  • 8.13 GASTROINTESTINAL DISEASES
    • 8.13.1 RAPID LIFESTYLE AND DIETARY CHANGES TO AMPLIFY GROWTH
  • 8.14 GENITOURINARY & WOMEN'S HEALTH
    • 8.14.1 RISING AWARENESS ABOUT EARLY DISEASE DIAGNOSIS AND TREATMENT TO BOLSTER GROWTH
  • 8.15 HEMATOLOGY
    • 8.15.1 INCREASING DRUG APPROVALS FOR DRUGS AGAINST NON-MALIGNANT HEMATOLOGICAL CONDITIONS TO SUPPORT GROWTH
  • 8.16 OTHER THERAPEUTIC AREAS

9 CRO SERVICES MARKET, BY MODALITY

  • 9.1 INTRODUCTION
  • 9.2 SMALL MOLECULES
    • 9.2.1 ONGOING SURGE IN PHARMACEUTICAL R&D INVESTMENTS TO SUPPORT GROWTH
  • 9.3 BIOLOGICS
    • 9.3.1 MONOCLONAL ANTIBODY
      • 9.3.1.1 Surging demand for targeted therapies across oncology, autoimmune disorders, and infectious diseases to drive market
    • 9.3.2 CELL & GENE THERAPY
      • 9.3.2.1 Robust drug pipeline and R&D initiatives to drive market
    • 9.3.3 OTHER BIOLOGICS
  • 9.4 MEDICAL DEVICES
    • 9.4.1 RAPID INNOVATIONS IN DIAGNOSTICS, IMPLANTABLE, AND DIGITAL HEALTH TECHNOLOGIES TO FOSTER GROWTH
  • 9.5 BIOSIMILARS
    • 9.5.1 MONOCLONAL ANTIBODY BIOSIMILARS
      • 9.5.1.1 Rising demand for affordable therapeutic options to support growth
    • 9.5.2 INSULIN
      • 9.5.2.1 Increasing patent expirations to contribute to growth
    • 9.5.3 COLONY STIMULATING FACTOR
      • 9.5.3.1 Increasing use of colony stimulating factor during post-chemotherapy to aid growth
    • 9.5.4 ERYTHROPOEITIN
      • 9.5.4.1 Essential role of erythropoietin in treating anemia to stimulate growth
    • 9.5.5 OTHER BIOSIMILARS

10 CRO SERVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • 10.2.1 INCREASING OUTSOURCING AND PARTNERSHIPS TO ACCELERATE GROWTH
  • 10.3 MEDICAL DEVICE COMPANIES
    • 10.3.1 INCREASING RECOGNITION OF CRO PROVIDERS TO AUGMENT GROWTH
  • 10.4 ACADEMIC INSTITUTES
    • 10.4.1 CONSISTENT COLLABORATIONS BETWEEN CROS AND ACADEMIA TO INTENSIFY GROWTH

11 CRO SERVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Increasing incidence of oncology indications to accelerate growth
    • 11.2.3 CANADA
      • 11.2.3.1 Favorable government initiatives and high investments to support growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Presence of strong pharmaceutical and biotechnology R&D infrastructure to spur growth
    • 11.3.3 UK
      • 11.3.3.1 Rising R&D expenditure in pharmaceutical industry to expedite growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Increasing technological advancements and faster drug discovery and development initiatives to aid growth
    • 11.3.5 ITALY
      • 11.3.5.1 Short timeline for drug approvals to encourage growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Growing investment in pharmaceutical industry to boost market
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Continued efforts on improving level of drug safety and supply to spur growth
    • 11.4.3 INDIA
      • 11.4.3.1 Large pool of patients and presence of highly skilled medical professionals to augment growth
    • 11.4.4 JAPAN
      • 11.4.4.1 Growing drug development activity to propel market
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Growing focus on funding opportunities to boost market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Emerging clinical research hub to sustain growth
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Growing focus on enhancing pharmaceutical research and production to fuel market
    • 11.5.3 MEXICO
      • 11.5.3.1 Increasing investments in pharma R&D to promote growth
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Kingdom of Saudi Arabia (KSA)
        • 11.6.2.1.1 Expanding clinical trials ecosystem to contribute to growth
      • 11.6.2.2 United Arab Emirates (UAE)
        • 11.6.2.2.1 Growing clinical trials activity to drive market
        • 11.6.2.2.2 Rest of GCC Countries
      • 11.6.2.3 Rest of Middle East
  • 11.7 AFRICA
    • 11.7.1 BOOMING PHARMACEUTICAL INDUSTRY TO FACILITATE GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CRO SERVICES MARKET
  • 12.3 REVENUE ANALYSIS, 2020-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 BRAND/SERVICE COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Region footprint
      • 12.7.5.3 Type footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 SERVICE/SOLUTION LAUNCHES AND APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 IQVIA INC.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Services/Solutions offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Service/Solution launches and approvals
        • 13.1.1.3.2 Deals
        • 13.1.1.3.3 Other developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 ICON PLC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Services/Solutions offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Service/Solution launches and approvals
        • 13.1.2.3.2 Deals
        • 13.1.2.3.3 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 THERMO FISHER SCIENTIFIC INC.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Services/Solutions offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Service/Solution launches and approvals
        • 13.1.3.3.2 Deals
        • 13.1.3.3.3 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 LABCORP
      • 13.1.4.1 Business overview
      • 13.1.4.2 Services/Solutions offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Service/Solution launches and approvals
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Expansions
        • 13.1.4.3.4 Other developments
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 FORTREA, INC.
      • 13.1.5.1 Company overview
      • 13.1.5.2 Services/Solutions offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Service/Solution launches and approvals
        • 13.1.5.3.2 Deals
        • 13.1.5.3.3 Expansions
        • 13.1.5.3.4 Other developments
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 SYNEOS HEALTH
      • 13.1.6.1 Business overview
      • 13.1.6.2 Services/Solutions offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Service/Solution launches and approvals
        • 13.1.6.3.2 Deals
    • 13.1.7 WUXI APPTEC
      • 13.1.7.1 Business overview
      • 13.1.7.2 Services/Solutions offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Service/Solution launches and approvals
        • 13.1.7.3.2 Deals
        • 13.1.7.3.3 Expansions
    • 13.1.8 CHARLES RIVER LABORATORIES
      • 13.1.8.1 Business overview
      • 13.1.8.2 Services/Solutions offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Deals
        • 13.1.8.3.2 Expansions
    • 13.1.9 PAREXEL INTERNATIONAL CORPORATION
      • 13.1.9.1 Business overview
      • 13.1.9.2 Services/Solutions offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Service/Solution launches and approvals
        • 13.1.9.3.2 Deals
        • 13.1.9.3.3 Expansions
    • 13.1.10 PHARMARON
      • 13.1.10.1 Business overview
      • 13.1.10.2 Services/Solutions offered
    • 13.1.11 MEDPACE
      • 13.1.11.1 Business overview
      • 13.1.11.2 Services/Solutions offered
    • 13.1.12 SGS SOCIETE GENERALE DE SURVEILLANCE SA
      • 13.1.12.1 Business overview
      • 13.1.12.2 Services/Solutions offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Deals
    • 13.1.13 FRONTAGE LABS
      • 13.1.13.1 Business overview
      • 13.1.13.2 Services/Solutions offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Deals
        • 13.1.13.3.2 Expansions
        • 13.1.13.3.3 Other developments
    • 13.1.14 EUROFINS SCIENTIFIC
      • 13.1.14.1 Business overview
      • 13.1.14.2 Services/Solutions offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Deals
    • 13.1.15 TIGERMED
      • 13.1.15.1 Business overview
      • 13.1.15.2 Services/Solutions offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Service/Solution launches and approvals
        • 13.1.15.3.2 Deals
    • 13.1.16 PSI
      • 13.1.16.1 Business overview
      • 13.1.16.2 Services/Solutions offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Service/Solution launches and approvals
        • 13.1.16.3.2 Deals
        • 13.1.16.3.3 Expansions
    • 13.1.17 BIOAGILE THERAPEUTICS PRIVATE LIMITED
      • 13.1.17.1 Business overview
      • 13.1.17.2 Services/Solutions offered
    • 13.1.18 FIRMA CLINICAL RESEARCH
      • 13.1.18.1 Business overview
      • 13.1.18.2 Services/Solutions offered
    • 13.1.19 ACCULAB LIFE SCIENCES
      • 13.1.19.1 Business overview
      • 13.1.19.2 Services/Solutions offered
    • 13.1.20 NOVOTECH
      • 13.1.20.1 Business overview
      • 13.1.20.2 Services/Solutions offered
      • 13.1.20.3 Recent developments
        • 13.1.20.3.1 Deals
    • 13.1.21 LINICAL
      • 13.1.21.1 Business overview
      • 13.1.21.2 Services/Solutions offered
      • 13.1.21.3 Recent developments
        • 13.1.21.3.1 Deals
        • 13.1.21.3.2 Expansions
    • 13.1.22 ADVANCED CLINICAL
      • 13.1.22.1 Business overview
      • 13.1.22.2 Services/Solutions offered
      • 13.1.22.3 Recent developments
        • 13.1.22.3.1 Deals
        • 13.1.22.3.2 Expansions
  • 13.2 OTHER PLAYERS
    • 13.2.1 ALLUCENT
    • 13.2.2 EMVENIO
    • 13.2.3 GUIRES INC.
    • 13.2.4 WORLDWIDE CLINICAL TRIALS
    • 13.2.5 CTI CLINICAL TRIAL & CONSULTING

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CRO SERVICES MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 CRO SERVICES MARKET: RISK ANALYSIS
  • TABLE 4 CRO SERVICES MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
  • TABLE 5 CRO SERVICES MARKET: EMERGING BUSINESS MODELS AND TARGET SEGMENTS
  • TABLE 6 CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 7 INDICATIVE PRICING ANALYSIS, BY SERVICE TYPE, 2024 (USD)
  • TABLE 8 INDICATIVE PRICING ANALYSIS, BY PHASE, 2024 (USD MILLION)
  • TABLE 9 INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
  • TABLE 10 CRO SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 11 CRO SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 CRO SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
  • TABLE 18 KEY BUYING CRITERIA, BY END USER
  • TABLE 19 CRO SERVICES MARKET: ADOPTION BARRIER AND INTERNAL FRICTION
  • TABLE 20 CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 21 NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES AS OF AUGUST 2024, BY LOCATION
  • TABLE 22 CLINICAL RESEARCH SERVICES OFFERED BY MARKET PLAYERS
  • TABLE 23 CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 24 CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 25 NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 26 EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 EUROPE: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 EUROPE: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 LATIN AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 MIDDLE EAST: CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 EUROPE: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 LATIN AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 MIDDLE EAST: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 EUROPE: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 MIDDLE EAST: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 97 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 EUROPE: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 EUROPE: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 LATIN AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 108 MIDDLE EAST: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 LABORATORY SERVICES OFFERED BY KEY PLAYERS
  • TABLE 111 CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 113 NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 114 EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 118 GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 128 NORTH AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 EUROPE: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 LATIN AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 132 MIDDLE EAST: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 133 GCC COUNTRIES: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 134 CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 EUROPE: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 LATIN AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 139 MIDDLE EAST: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 GCC COUNTRIES: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 142 NORTH AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 EUROPE: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 LATIN AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 147 GCC COUNTRIES: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 148 CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 149 NORTH AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 EUROPE: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 152 LATIN AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 153 MIDDLE EAST: CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 155 CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 156 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 EUROPE: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 159 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 160 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 162 CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 163 NORTH AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 164 EUROPE: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 LATIN AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 MIDDLE EAST: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 CONSULTING SERVICES OFFERED BY PROMINENT PLAYERS
  • TABLE 170 CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 171 NORTH AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 172 EUROPE: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 LATIN AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 177 CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 EUROPE: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 LATIN AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 MIDDLE EAST: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 184 CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 185 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
  • TABLE 186 CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 188 NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 189 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 192 MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 193 GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 194 CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 195 NORTH AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 196 EUROPE: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 198 LATIN AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST: CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 200 GCC COUNTRIES: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 201 CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 202 NORTH AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 203 EUROPE: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST: CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 207 GCC COUNTRIES: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 208 CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 209 NORTH AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 210 EUROPE: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 212 LATIN AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 213 MIDDLE EAST: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 214 GCC COUNTRIES: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 215 CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 216 NORTH AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 217 EUROPE: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 219 LATIN AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST: CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 222 NUMBER OF DRUGS IN R&D PIPELINE FOR OTHER CANCERS, 2023-2024
  • TABLE 223 CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 224 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 225 EUROPE: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 227 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 230 CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 231 NORTH AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 232 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY INFECTIOUS DISEASES, 2023-2030 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 234 LATIN AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 237 CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 238 NORTH AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 239 EUROPE: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 241 LATIN AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 244 CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 245 NORTH AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 246 EUROPE: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 248 LATIN AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 249 MIDDLE EAST: CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 251 CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 252 NORTH AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 253 EUROPE: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 255 LATIN AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 256 MIDDLE EAST: CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 258 CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 259 NORTH AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 260 EUROPE: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 262 LATIN AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 263 MIDDLE EAST: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 265 CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 266 NORTH AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 267 EUROPE: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 268 ASIA PACIFIC: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 269 LATIN AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 270 MIDDLE EAST: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 271 GCC COUNTRIES: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 272 CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 273 NORTH AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 274 EUROPE: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 276 LATIN AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 277 MIDDLE EAST: CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 279 CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 280 NORTH AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 281 EUROPE: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 283 LATIN AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 284 MIDDLE EAST: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 286 CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 287 NORTH AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 288 EUROPE: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 290 LATIN AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 291 MIDDLE EAST: CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 292 GCC COUNTRIES: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 293 CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 294 NORTH AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 295 EUROPE: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 297 LATIN AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 298 MIDDLE EAST: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 299 GCC COUNTRIES: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 300 CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 301 NORTH AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 302 EUROPE: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 303 ASIA PACIFIC: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 304 LATIN AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 305 MIDDLE EAST: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 306 GCC COUNTRIES: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 307 CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 308 NORTH AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 309 EUROPE: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 311 LATIN AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 312 MIDDLE EAST: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 313 GCC COUNTRIES: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 314 CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 315 NORTH AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 316 EUROPE: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 318 LATIN AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 319 MIDDLE EAST: CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 320 GCC COUNTRIES: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 321 CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 322 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 323 EUROPE: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 325 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 326 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 328 CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 329 CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 330 NORTH AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 331 EUROPE: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 333 LATIN AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 334 MIDDLE EAST: CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 335 GCC COUNTRIES: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 336 CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 337 NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 338 EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 340 LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 341 MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 342 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 343 CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 345 NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 346 EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 348 LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 349 MIDDLE EAST: CRO SERVICES BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 351 CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 352 NORTH AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 353 EUROPE: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 354 ASIA PACIFIC: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 355 LATIN AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 356 MIDDLE EAST: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 358 CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 359 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 360 EUROPE: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 361 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 362 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 363 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 364 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 365 CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 366 NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 367 EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 369 LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 370 MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 372 CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 373 NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 374 EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 375 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 376 LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 377 MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 378 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 379 CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 380 CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 381 NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 382 EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 384 LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 385 MIDDLE EAST: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 386 GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 387 CRO SERVICES MARKET FOR INSULIN, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 388 NORTH AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 389 EUROPE: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 391 LATIN AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 392 MIDDLE EAST: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 393 GCC COUNTRIES: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 394 CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 395 NORTH AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 396 EUROPE: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 397 ASIA PACIFIC: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 398 LATIN AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 399 MIDDLE EAST: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: CRO SERVICES BIOSIMILARS MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 401 CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 402 NORTH AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 403 EUROPE: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 404 ASIA PACIFIC: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 405 LATIN AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 406 MIDDLE EAST: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 407 GCC COUNTRIES: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 408 CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 409 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 410 EUROPE: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 411 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 412 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 413 MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 414 GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 415 CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 416 CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 417 NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 418 EUROPE: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 419 ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 420 LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 421 MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 423 CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 424 NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 425 EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 426 ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 427 LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 428 MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 430 CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 431 NORTH AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 432 EUROPE: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 433 ASIA PACIFIC: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 434 LATIN AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 435 MIDDLE EAST: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 436 GCC COUNTRIES: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 437 CRO SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 438 NORTH AMERICA: CRO SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 439 NORTH AMERICA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 440 NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 441 NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 442 NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 443 NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 444 NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 445 NORTH AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 446 NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 447 NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 448 NORTH AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 449 NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 450 NORTH AMERICA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 451 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 452 US: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 453 US: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 454 US: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 455 US: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 456 US: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 457 US: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 458 US: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 459 US: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 460 US: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 461 US: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 462 US: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 463 US: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 464 CANADA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 465 CANADA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 466 CANADA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 467 CANADA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 468 CANADA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 469 CANADA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 470 CANADA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 471 CANADA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 472 CANADA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 473 CANADA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 474 CANADA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 475 CANADA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 476 EUROPE: CRO SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 477 EUROPE: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 478 EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 479 EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 480 EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 481 EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 482 EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 483 EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 484 EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 485 EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 486 EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 487 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 488 EUROPE: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 489 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 490 GERMANY: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 491 GERMANY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 492 GERMANY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 493 GERMANY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 494 GERMANY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 495 GERMANY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 496 GERMANY: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 497 GERMANY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 498 GERMANY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 499 GERMANY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 500 GERMANY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 501 GERMANY: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 502 UK: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 503 UK: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 504 UK: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 505 UK: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 506 UK: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 507 UK: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 508 UK: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 509 UK: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 510 UK: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 511 UK: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 512 UK: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 513 UK: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 514 FRANCE: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 515 FRANCE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 516 FRANCE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 517 FRANCE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 518 FRANCE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 519 FRANCE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 520 FRANCE: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 521 FRANCE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 522 FRANCE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 523 FRANCE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 524 FRANCE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 525 FRANCE: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 526 ITALY: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 527 ITALY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 528 ITALY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 529 ITALY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 530 ITALY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 531 ITALY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 532 ITALY: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 533 ITALY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 534 ITALY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 535 ITALY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 536 ITALY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 537 ITALY: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 538 SPAIN: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 539 SPAIN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 540 SPAIN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 541 SPAIN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 542 SPAIN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 543 SPAIN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 544 SPAIN: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 545 SPAIN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 546 SPAIN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 547 SPAIN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 548 SPAIN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 549 SPAIN: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 550 REST OF EUROPE: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 551 REST OF EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 552 REST OF EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 553 REST OF EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 554 REST OF EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 555 REST OF EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 556 REST OF EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 557 REST OF EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 558 REST OF EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 559 REST OF EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 560 REST OF EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 561 REST OF EUROPE: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 562 ASIA PACIFIC: CRO SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 563 ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 564 ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 565 ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 566 ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 567 ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 568 ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 569 ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 570 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 571 ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 572 ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 573 ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 574 ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 575 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 576 CHINA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 577 CHINA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 578 CHINA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 579 CHINA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 580 CHINA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 581 CHINA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 582 CHINA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 583 CHINA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 584 CHINA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 585 CHINA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 586 CHINA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 587 CHINA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 588 INDIA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 589 INDIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 590 INDIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 591 INDIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 592 INDIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 593 INDIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 594 INDIA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 595 INDIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 596 INDIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 597 INDIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 598 INDIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 599 INDIA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 600 JAPAN: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 601 JAPAN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 602 JAPAN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 603 JAPAN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 604 JAPAN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 605 JAPAN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 606 JAPAN: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 607 JAPAN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 608 JAPAN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 609 JAPAN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 610 JAPAN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 611 JAPAN: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 612 AUSTRALIA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 613 AUSTRALIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 614 AUSTRALIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 615 AUSTRALIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 616 AUSTRALIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 617 AUSTRALIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 618 AUSTRALIA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 619 AUSTRALIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 620 AUSTRALIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 621 AUSTRALIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 622 AUSTRALIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 623 AUSTRALIA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 624 SOUTH KOREA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 625 SOUTH KOREA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 626 SOUTH KOREA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 627 SOUTH KOREA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 628 SOUTH KOREA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 629 SOUTH KOREA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 630 SOUTH KOREA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 631 SOUTH KOREA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 632 SOUTH KOREA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 633 SOUTH KOREA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 634 SOUTH KOREA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 635 SOUTH KOREA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 636 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 637 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 638 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 639 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 640 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 641 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 642 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 643 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 644 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 645 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 646 REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 647 REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 648 LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 649 LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 650 LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 651 LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 652 LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 653 LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 654 LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 655 LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 656 LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 657 LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 658 LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 659 LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 660 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 661 BRAZIL: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 662 BRAZIL: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 663 BRAZIL: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 664 BRAZIL: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 665 BRAZIL: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 666 BRAZIL: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 667 BRAZIL: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 668 BRAZIL: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 669 BRAZIL: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 670 BRAZIL: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 671 BRAZIL: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 672 BRAZIL: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 673 MEXICO: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 674 MEXICO: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 675 MEXICO: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 676 MEXICO: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 677 MEXICO: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 678 MEXICO: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 679 MEXICO: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 680 MEXICO: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 681 MEXICO: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 682 MEXICO: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 683 MEXICO: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 684 MEXICO: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 685 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 686 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 687 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 688 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 689 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 690 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 691 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 692 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 693 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 694 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 695 REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 696 REST OF LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 697 MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 698 MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 699 MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 700 MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 701 MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 702 MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 703 MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 704 MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 705 MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 706 MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 707 MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 708 MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 709 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
  • TABLE 710 GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 711 GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 712 GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 713 GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 714 GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 715 GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 716 GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 717 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 718 GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 719 GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 720 GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 721 GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 722 GCC COUNTRIES: CRO SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 723 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 724 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 725 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 726 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 727 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 728 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 729 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 730 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 731 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 732 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 733 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 734 KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 735 UAE: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 736 UAE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 737 UAE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 738 UAE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 739 UAE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 740 UAE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 741 UAE: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 742 UAE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 743 UAE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 744 UAE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 745 UAE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 746 UAE: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 747 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 748 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 749 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 750 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 751 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 752 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 753 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 754 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 755 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 756 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 757 REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 758 REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 759 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 760 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 761 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 762 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 763 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 764 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 765 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 766 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 767 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 768 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 769 REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 770 REST OF MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 771 AFRICA: CRO SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 772 AFRICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023-2030 (USD MILLION)
  • TABLE 773 AFRICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 774 AFRICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 775 AFRICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 776 AFRICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 777 AFRICA: CRO SERVICES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 778 AFRICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 779 AFRICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 780 AFRICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 781 AFRICA: CRO SERVICES MARKET FOR ONCOLOGY MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 782 AFRICA: CRO SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 783 AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 784 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CRO SERVICES MARKET, JANUARY 2021-AUGUST 2025
  • TABLE 785 CRO SERVICES MARKET: DEGREE OF COMPETITION
  • TABLE 786 CRO SERVICES MARKET: REGION FOOTPRINT
  • TABLE 787 CRO SERVICES MARKET: TYPE FOOTPRINT
  • TABLE 788 CRO SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 789 CRO SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 790 CRO SERVICES MARKET: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 791 CRO SERVICES MARKET: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 792 CRO SERVICES MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 793 IQVIA INC.: COMPANY OVERVIEW
  • TABLE 794 IQVIA INC.: SERVICES/SOLUTIONS OFFERED
  • TABLE 795 IQVIA INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 796 IQVIA INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 797 IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2025
  • TABLE 798 ICON PLC: COMPANY OVERVIEW
  • TABLE 799 ICON PLC: SERVICES/SOLUTIONS OFFERED
  • TABLE 800 ICON PLC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 801 ICON PLC: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 802 ICON PLC: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 803 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 804 THERMO FISHER SCIENTIFIC INC.: SERVICES/SOLUTIONS OFFERED
  • TABLE 805 THERMO FISHER SCIENTIFIC, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 806 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 807 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 808 LABCORP: COMPANY OVERVIEW
  • TABLE 809 LABCORP: SERVICES/SOLUTIONS OFFERED
  • TABLE 810 LABCORP: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 811 LABCORP: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 812 LABCORP: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 813 LABCORP: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2025
  • TABLE 814 FORTREA, INC.: COMPANY OVERVIEW
  • TABLE 815 FORTREA, INC.: SERVICES/SOLUTIONS OFFERED
  • TABLE 816 FORTREA, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 817 FORTREA, INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 818 FORTREA, INC.: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 819 FORTREA, INC.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2025
  • TABLE 820 SYNEOS HEALTH: COMPANY OVERVIEW
  • TABLE 821 SYNEOS HEALTH: SERVICES/SOLUTIONS OFFERED
  • TABLE 822 SYNEOS HEALTH: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 823 SYNEOS HEALTH: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 824 WUXI APPTEC: COMPANY OVERVIEW
  • TABLE 825 WUXI APPTEC: SERVICES/SOLUTIONS OFFERED
  • TABLE 826 WUXI APPTEC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 827 WUXI APPTEC: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 828 WUXI APPTEC: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 829 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 830 CHARLES RIVER LABORATORIES: SERVICES/SOLUTIONS OFFERED
  • TABLE 831 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 832 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 833 PAREXEL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
  • TABLE 834 PAREXEL INTERNATIONAL CORPORATION: SERVICES/SOLUTIONS OFFERED
  • TABLE 835 PAREXEL INTERNATIONAL CORPORATION: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 836 PAREXEL INTERNATIONAL CORPORATION: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 837 PAREXEL INTERNATIONAL CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 838 PHARMARON: COMPANY OVERVIEW
  • TABLE 839 PHARMARON: SERVICES/SOLUTIONS OFFERED
  • TABLE 840 MEDPACE: COMPANY OVERVIEW
  • TABLE 841 MEDPACE: SERVICES/SOLUTIONS OFFERED
  • TABLE 842 SGS SOCIETE GENERALE DE SURVEILLANCE SA: COMPANY OVERVIEW
  • TABLE 843 SGS SOCIETE GENERALE DE SURVEILLANCE SA: SERVICES/SOLUTIONS OFFERED
  • TABLE 844 SGS SOCIETE GENERALE DE SURVEILLANCE SA: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 845 FRONTAGE LABS: COMPANY OVERVIEW
  • TABLE 846 FRONTAGE LABS: SERVICES/SOLUTIONS OFFERED
  • TABLE 847 FRONTAGE LABS: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 848 FRONTAGE LABS: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 849 FRONTAGE LABS: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2025
  • TABLE 850 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 851 EUROFINS SCIENTIFIC: SERVICES/SOLUTIONS OFFERED
  • TABLE 852 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 853 TIGERMED: COMPANY OVERVIEW
  • TABLE 854 TIGERMED: SERVICES/SOLUTIONS OFFERED
  • TABLE 855 TIGERMED: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 856 TIGERMED: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 857 PSI: COMPANY OVERVIEW
  • TABLE 858 PSI: SERVICES/SOLUTIONS OFFERED
  • TABLE 859 PSI: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 860 PSI: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 861 PSI: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 862 BIOAGILE: COMPANY OVERVIEW
  • TABLE 863 BIOAGILE: SERVICES/SOLUTIONS OFFERED
  • TABLE 864 FIRMA CLINICAL RESEARCH: COMPANY OVERVIEW
  • TABLE 865 FIRMA CLINICAL RESEARCH: SERVICES/SOLUTIONS OFFERED
  • TABLE 866 ACCULAB LIFE SCIENCES: COMPANY OVERVIEW
  • TABLE 867 ACCULAB LIFE SCIENCES: SERVICES/SOLUTIONS OFFERED
  • TABLE 868 NOVOTECH: COMPANY OVERVIEW
  • TABLE 869 NOVOTECH: SERVICES/SOLUTIONS OFFERED
  • TABLE 870 NOVOTECH: DEALS, JANUARY 2021-JULY 2025
  • TABLE 871 LINICAL: COMPANY OVERVIEW
  • TABLE 872 LINICAL: SERVICES/SOLUTIONS OFFERED
  • TABLE 873 LINICAL: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 874 LINICAL: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 875 ADVANCED CLINICAL: COMPANY OVERVIEW
  • TABLE 876 ADVANCED CLINICAL: SERVICES/SOLUTIONS OFFERED
  • TABLE 877 ADVANCED CLINICAL: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 878 ADVANCED CLINICAL: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 879 ALLUCENT: COMPANY OVERVIEW
  • TABLE 880 EMVENIO: COMPANY OVERVIEW
  • TABLE 881 GUIRES INC.: COMPANY OVERVIEW
  • TABLE 882 WORLDWIDE CLINICAL TRIALS: COMPANY OVERVIEW
  • TABLE 883 CTI CLINICAL TRIAL & CONSULTING: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 CRO SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 CRO SERVICES MARKET: RESEARCH DESIGN
  • FIGURE 3 CRO SERVICES MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 4 GLOBAL CRO SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 5 GLOBAL CRO SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF IQVIA INC.: REVENUE SHARE ANALYSIS, 2024
  • FIGURE 7 CRO SERVICES MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 CRO SERVICES MARKET: SUPPLY-SIDE AND DEMAND-SIDE ANALYSIS AND TRIANGULATION
  • FIGURE 9 CRO SERVICES MARKET: DEMAND-SIDE ANALYSIS, 2024
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 GLOBAL CRO SERVICES MARKET: CAGR PROJECTIONS, 2025-2030
  • FIGURE 12 CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • FIGURE 13 CRO SERVICES MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 CRO SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 CRO SERVICES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 CRO SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 REGIONAL SNAPSHOT OF CRO SERVICES MARKET
  • FIGURE 19 INCREASING CLINICAL PIPELINE AND RISING TRIAL VOLUME TO DRIVE MARKET
  • FIGURE 20 US AND SMALL MOLECULES SEGMENT LED NORTH AMERICAN MARKET IN 2024
  • FIGURE 21 CLINICAL RESEARCH SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
  • FIGURE 22 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT DOMINATED MARKET IN 2024
  • FIGURE 23 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 24 CRO SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 ACTIVE PHARMACEUTICAL PIPELINE, 2013-2024
  • FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR CRO SERVICES MARKET
  • FIGURE 27 INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
  • FIGURE 28 CRO SERVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 29 CRO SERVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 CRO SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
  • FIGURE 32 KEY BUYING CRITERIA, BY END USER
  • FIGURE 33 DRUGS IN PIPELINE, BY DEVELOPMENT PHASE, 2023 VS. 2024
  • FIGURE 34 PROPORTION OF PIPELINE IN DEVELOPMENT FOR CANCER, 2013-2024
  • FIGURE 35 ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES, 2000-2045 (MILLION)
  • FIGURE 36 ANNUAL DRUG APPROVALS BY CENTER FOR DRUG EVALUATION AND RESEARCH (FDA), 2012-2024
  • FIGURE 37 R&D SPENDING OF PHRMA MEMBER COMPANIES, 2012-2023
  • FIGURE 38 US FDA DE NOVO MEDICAL DEVICE APPROVALS, 2012-2024
  • FIGURE 39 NORTH AMERICA: CRO SERVICES MARKET SNAPSHOT
  • FIGURE 40 GLOBAL DISTRIBUTION OF R&D COMPANIES, JANUARY 2024 VS. JANUARY 2025
  • FIGURE 41 ASIA PACIFIC: CRO SERVICES MARKET SNAPSHOT
  • FIGURE 42 CRO SERVICES MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020-2024
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CRO SERVICES MARKET, 2024
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 CRO SERVICES MARKET: BRAND/SERVICE COMPARISON
  • FIGURE 47 CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 48 CRO SERVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 49 CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 50 IQVIA INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 51 ICON PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 LABCORP: COMPANY SNAPSHOT (2024)
  • FIGURE 54 FORTREA, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 WUXI APPTEC: COMPANY SNAPSHOT (2024)
  • FIGURE 56 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 57 PHARMARON: COMPANY SNAPSHOT (2024)
  • FIGURE 58 MEDPACE: COMPANY SNAPSHOT (2024)
  • FIGURE 59 SGS SOCIETE GENERALE DE SURVEILLANCE SA: COMPANY SNAPSHOT (2024)
  • FIGURE 60 FRONTAGE LABS: COMPANY SNAPSHOT (2024)
  • FIGURE 61 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
  • FIGURE 62 TIGERMED: COMPANY SNAPSHOT (2024)